NCT02407327 2023-11-01
2012/52
Istituto Oncologico Veneto IRCCS
Completed
Clinical Trials
4 trialsNCT03452150 2023-04-25
D-0316 First Time in Patients Ascending Dose Study
InventisBio Co., Ltd
Phase 1 Completed
NCT03351361 2023-03-01
eNERGY
Rennes University Hospital
Phase 3 Completed
NCT03652857 2020-02-17
Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 2 Completed